RESUMEN
Disseminated fusariosis is a life-threatening, invasive, opportunistic infection in immunocompromised patients, especially those with haematological malignancies. The prognosis is poor because these fungi are resistant to many of the available antifungal agents. We present a case of disseminated fusariosis caused by Fusarium proliferatum in a patient with severe aplastic anaemia complicated by a secondary infection of Aspergillus flavus, with a fatal outcome. We also review the documented Fusarium infections in immunocompromised hosts.
Asunto(s)
Anemia Aplásica/complicaciones , Antifúngicos/uso terapéutico , Fusariosis/diagnóstico , Huésped Inmunocomprometido , Infecciones Oportunistas/diagnóstico , Triazoles/uso terapéutico , Antifúngicos/farmacología , Aspergilosis/complicaciones , Aspergilosis/microbiología , Aspergillus flavus/efectos de los fármacos , Aspergillus flavus/aislamiento & purificación , Coinfección , Resultado Fatal , Fusariosis/complicaciones , Fusariosis/tratamiento farmacológico , Fusariosis/microbiología , Fusarium/efectos de los fármacos , Fusarium/aislamiento & purificación , Humanos , Masculino , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/microbiología , Adulto JovenRESUMEN
BACKGROUND: Antiviral resistance development is a serious complication of human cytomegalovirus virostatic therapy caused by mutations in UL 97 and/or UL54 genes. OBJECTIVES: To determinate the presence of sensitive and resistant strains in patients developing antiviral resistance. STUDY DESIGN: We used three different molecular biological methods for mutation analysis-restriction fragment length polymorphism, sequencing and real-time PCR approach. RESULTS: We describe three allogeneic hematopoietic stem cell transplant patients developing the GCV resistant HCMV strains manifested by virostatic treatment failure. In these patients we identified UL97 mutations L595S, A594V and A594T and monitored the dynamics of coexisted sensitive/resistant strains. We confirmed the presence of mixed HCMV populations and in two patients a phenomenon of sensitive strain repopulation which occurred after 6.5 months and 1 month after removing GCV pressure. CONCLUSIONS: Our results show changes in proportions of sensitive/resistant subpopulations over time but other studies would be required to demonstrate the beneficial impact of their monitoring on clinical outcome.